Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: CYTOSORBENTS MEDICAL INC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Department of the Army
Period of performance: 2022-08-22 to 2025-12-21
Current total value of award: $4292641
Description: DHA SBIR PHASE III PROPOSAL JW210458 INTEGRATING ISOAGGLUTININ REDUCTION FOR A UNIVERSAL DRIED PLASMA PRODUCT FOR BATTLEFIELD AND FIRST RESPONDER USE